Merck KGaA Articles
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
EMEA: No change to Gardasil labeling
4 February 2008
FDA clears Merck & Co's Emend Injection for CINV
4 February 2008
Iroko acquires rights to Merck & Co CV compound
4 February 2008
EMEA's PDCO issues PIP review opinions
4 February 2008
Vioxx costs see Merck & Co swing to $1.6B loss
4 February 2008
wt-KRAS as Erbitux efficacy biomarker
4 February 2008
S-P/Merck & Co account for ENHANCE delay
4 February 2008
Merck & Co's Isentress launched in UK
28 January 2008
Stock Commentary - New York week to Jan 21, 2008
28 January 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Brazil's pipeline patents under threat
28 January 2008
Drugmakers accused of delaying ENHANCE data
28 January 2008
US clinic ships 19,000 drug firm gifts to Cameroon
28 January 2008
Merck KGaA plans job cuts at Spanish plant
21 January 2008
UPDATE: Raids on major drugmakers as EU Commission starts pharma sector inquiry with unannounced inspections
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
France adopts Gardasil as human papillomavirus vaccine
21 January 2008
Merck & Co Vioxx settlement likely
21 January 2008
Meta-analysis in The Lancet recommends statins for all diabetics, regardless of CV risk
21 January 2008
Strong data for Merck & Co's taranabant
21 January 2008
FDA clears orphan drug Kuvan for PKU
14 January 2008
FDA warns: severe pain with bisphosphonates
14 January 2008
US new drug approvals hit 24-year low
14 January 2008
Actelion becomes full member of Swiss Interpharma
14 January 2008
Patent expiry for 2008 provides generic opportunity
14 January 2008
Japan stock market week to Nov 14
7 January 2008
Mark Timney adds to his role at Merck & Co group
7 January 2008
EC OKs Isentress for treatment-experienced HIV-1 patients
7 January 2008
Stock Commentary - Europe - week to January 7, 2008
7 January 2008
PRWT buys Merck & Co chemical facility
7 January 2008
Merck Serono and Flamel accord of Medusa technology
7 January 2008
EC approves B-MS/Gilead's Atripla
24 December 2007
Merck KGaA licenses Idera's TLR9 agonists
24 December 2007
Merck Serono announces web site launch
24 December 2007
Merck & Co hit by US Clean Water Act fines
24 December 2007
FDA panel says no to OTC statin Mevacor
24 December 2007
Merck & Co recalls certain lots of Pedvaxhib and Comvax
17 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
Clinical Data pays milestone to Merck KGaA
17 December 2007
Headlines 25 years ago this week....
17 December 2007
ImClone/Sanofi sign $120M Yeda settlement
17 December 2007
Merck KGaA's 4.9B-euro sale of generics ops to Mylan completes
17 December 2007
PhRMA details Mexico flood relief by members
17 December 2007
Merck KGaA confirms end of diabetes R&D
10 December 2007
Merck KGaA seeks to expand Erbitux in mCRC
10 December 2007
Merck Serono's Cyanokit cleared in the EU
3 December 2007
Stock Commentary - New York week to Nov 26, 2007
3 December 2007
Merck & Co files MAA for vorinostat in CTCL
3 December 2007
Japan stock market week to Nov 26, 2007
3 December 2007
Merck Serono sets Ph III PD drug trial in MOTION
3 December 2007
NICE OK's Ezetrol for high cholesterol
3 December 2007
Sanofi-Aventis to invest in China vaccines plant
3 December 2007
Most UK NHS patients not told of drug options
26 November 2007
Merck & Co suspends enrollment in trial of lead Aurora kinase drug
26 November 2007
Stock Commentary - Europe - week to Nov 19
26 November 2007
Mylan completes $2.89B financing
26 November 2007
Nicholas Piramal and Merck sign R&D deal
26 November 2007
Erbitux improves overall survival in mCRC
26 November 2007
ENHANCE data now expected March 2008
26 November 2007
Harvard study finds Brazil saved $1B on ARVs
26 November 2007
Novartis' Prexige withdrawn by UK, German and Austrian regulators on liver safety fears
26 November 2007
Merck & Co's Isentress gets nod from CHMP
26 November 2007
Pfizer makes $164M bid for Coley Pharma to expand in vaccines
26 November 2007
Merck Serono files sapropterin MAA
19 November 2007
Mylan prices public offerings
19 November 2007
Stock Commentary - New York week to Nov 12, 2007
19 November 2007
Portugal offers free HPV vaccine to girls
19 November 2007
Merck KGaA pays Rigel $3M for Japanese right to cancer drug
19 November 2007
STEP volunteers to be told if they had placebo
19 November 2007
HIV vacc failure may be linked to Ad5 vector
19 November 2007
Thailand protests over drug supply reform
19 November 2007
Merck & Co to pay $4.85B to resolve Vioxx suits
19 November 2007
Genmab's 9-month 2007 revenues triple
12 November 2007
Dynavax and Merck & Co to co-develop Heplisav
12 November 2007
Betaseron linked to fewer injection site reactions
12 November 2007
Gardasil prevents 92% of HPV-related genital diseases
12 November 2007
Merck & Co to bring CV health message up to par
12 November 2007
US FDA clears Merck KGaA's easypod
12 November 2007
Mylan's earnings soar 94% in fiscal 2nd-qtr
12 November 2007
US Rx drug market in relative decline
12 November 2007
Stock Commentary - New York week to Oct 29, 2007
5 November 2007
UPDATE: HPV vaccine timetable revealed by UK govt
5 November 2007
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
